255 related articles for article (PubMed ID: 33726742)
1. The clinical characteristics, treatment, and survival of portopulmonary hypertension in Japan.
Takahashi Y; Yamamoto K; Sakao S; Takeuchi T; Suda R; Tanabe N; Tatsumi K
BMC Pulm Med; 2021 Mar; 21(1):89. PubMed ID: 33726742
[TBL] [Abstract][Full Text] [Related]
2. Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry.
Sithamparanathan S; Nair A; Thirugnanasothy L; Coghlan JG; Condliffe R; Dimopoulos K; Elliot CA; Fisher AJ; Gaine S; Gibbs JSR; Gatzoulis MA; E Handler C; Howard LS; Johnson M; Kiely DG; Lordan JL; Peacock AJ; Pepke-Zaba J; Schreiber BE; Sheares KKK; Wort SJ; Corris PA;
J Heart Lung Transplant; 2017 Jul; 36(7):770-779. PubMed ID: 28190786
[TBL] [Abstract][Full Text] [Related]
3. Portopulmonary hypertension: a report from the US-based REVEAL Registry.
Krowka MJ; Miller DP; Barst RJ; Taichman D; Dweik RA; Badesch DB; McGoon MD
Chest; 2012 Apr; 141(4):906-915. PubMed ID: 21778257
[TBL] [Abstract][Full Text] [Related]
4. Portopulmonary hypertension.
Krowka MJ
Semin Respir Crit Care Med; 2012 Feb; 33(1):17-25. PubMed ID: 22447257
[TBL] [Abstract][Full Text] [Related]
5. Portopulmonary Hypertension: Management and Liver Transplantation Evaluation.
DuBrock HM
Chest; 2023 Jul; 164(1):206-214. PubMed ID: 36649754
[TBL] [Abstract][Full Text] [Related]
6. Portopulmonary hypertension: prognosis and management in the current treatment era - results from the REHAP registry.
Lazaro Salvador M; Quezada Loaiza CA; Rodríguez Padial L; Barberá JA; López-Meseguer M; López-Reyes R; Sala-Llinas E; Alcolea S; Blanco I; Escribano-Subías P;
Intern Med J; 2021 Mar; 51(3):355-365. PubMed ID: 31943676
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Waitlist Mortality in Portopulmonary Hypertension.
DuBrock HM; Goldberg DS; Sussman NL; Bartolome SD; Kadry Z; Salgia RJ; Mulligan DC; Kremers WK; Kawut SM; Krowka MJ; Channick RN
Transplantation; 2017 Jul; 101(7):1609-1615. PubMed ID: 28207639
[TBL] [Abstract][Full Text] [Related]
8. Portopulmonary hypertension: survival and prognostic factors.
Le Pavec J; Souza R; Herve P; Lebrec D; Savale L; Tcherakian C; Jaïs X; Yaïci A; Humbert M; Simonneau G; Sitbon O
Am J Respir Crit Care Med; 2008 Sep; 178(6):637-43. PubMed ID: 18617641
[TBL] [Abstract][Full Text] [Related]
9. Protocol: Prospective observational study investigating the prevalence and clinical outcome of portopulmonary hypertension in Japanese patients with chronic liver disease.
Wakabayashi SI; Joshita S; Kimura K; Motoki H; Kobayashi H; Yamashita Y; Sugiura A; Yamazaki T; Kuwahara K; Umemura T
PLoS One; 2021; 16(4):e0249435. PubMed ID: 33793649
[TBL] [Abstract][Full Text] [Related]
10. Portopulmonary hypertension in the current era of pulmonary hypertension management.
Savale L; Guimas M; Ebstein N; Fertin M; Jevnikar M; Renard S; Horeau-Langlard D; Tromeur C; Chabanne C; Prevot G; Chaouat A; Moceri P; Artaud-Macari É; Degano B; Tresorier R; Boissin C; Bouvaist H; Simon AC; Riou M; Favrolt N; Palat S; Bourlier D; Magro P; Cottin V; Bergot E; Lamblin N; Jaïs X; Coilly A; Durand F; Francoz C; Conti F; Hervé P; Simonneau G; Montani D; Duclos-Vallée JC; Samuel D; Humbert M; De Groote P; Sitbon O
J Hepatol; 2020 Jul; 73(1):130-139. PubMed ID: 32145258
[TBL] [Abstract][Full Text] [Related]
11. Early initiation of prostacyclin in portopulmonary hypertension: 10 years of a transplant center's experience.
Awdish RL; Cajigas HR
Lung; 2013 Dec; 191(6):593-600. PubMed ID: 23979006
[TBL] [Abstract][Full Text] [Related]
12. Clinical aspects of portopulmonary hypertension.
Medarov BI; Chopra A; Judson MA
Respir Med; 2014 Jul; 108(7):943-54. PubMed ID: 24816204
[TBL] [Abstract][Full Text] [Related]
13. Effect of PAH specific therapy on pulmonary hemodynamics and six-minute walk distance in portopulmonary hypertension: a systematic review and meta-analysis.
Faisal M; Siddiqi F; Alkaddour A; Bajwa AA; Shujaat A
Pulm Med; 2014; 2014():528783. PubMed ID: 25478223
[TBL] [Abstract][Full Text] [Related]
14. Portopulmonary hypertension.
Barua UK; Hossain AS; Roy GC; Rahman MA; Das M
Mymensingh Med J; 2013 Jul; 22(3):618-24. PubMed ID: 23982562
[TBL] [Abstract][Full Text] [Related]
15. Treatment pattern and clinical outcomes in portopulmonary hypertension: A database study in Japan.
Atsukawa M; Takano M; Omura J
JGH Open; 2022 Nov; 6(11):763-773. PubMed ID: 36406647
[TBL] [Abstract][Full Text] [Related]
16. Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary Hypertension.
Nikolic I; Yung LM; Yang P; Malhotra R; Paskin-Flerlage SD; Dinter T; Bocobo GA; Tumelty KE; Faugno AJ; Troncone L; McNeil ME; Huang X; Coser KR; Lai CSC; Upton PD; Goumans MJ; Zamanian RT; Elliott CG; Lee A; Zheng W; Berasi SP; Huard C; Morrell NW; Chung RT; Channick RW; Roberts KE; Yu PB
Am J Respir Crit Care Med; 2019 Apr; 199(7):891-902. PubMed ID: 30312106
[TBL] [Abstract][Full Text] [Related]
17. [The portopulmonary hypertension: an overview from diagnosis to treatment].
Salzano A; Sirico D; Golia L; Faga V; Flora M; Bossone E; Cittadini A
Monaldi Arch Chest Dis; 2013 Jun; 80(2):66-8. PubMed ID: 24494409
[TBL] [Abstract][Full Text] [Related]
18. Sex Differences in Portopulmonary Hypertension.
DuBrock HM; Cartin-Ceba R; Channick RN; Kawut SM; Krowka MJ
Chest; 2021 Jan; 159(1):328-336. PubMed ID: 32798521
[TBL] [Abstract][Full Text] [Related]
19. Other causes of PAH (schistosomiasis, porto-pulmonary hypertension and hemolysis-associated pulmonary hypertension).
Souza R; Fernandes CJ; Jardim CV
Semin Respir Crit Care Med; 2009 Aug; 30(4):448-57. PubMed ID: 19634084
[TBL] [Abstract][Full Text] [Related]
20. Portopulmonary hypertension.
Lv Y; Han G; Fan D
Scand J Gastroenterol; 2016 Jul; 51(7):795-806. PubMed ID: 27002212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
